{
    "code": "02022066",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02022066",
    "time": "2020-02-25 12:50:12",
    "許可證字號": "衛署藥輸字第022066號",
    "註銷狀態": "已註銷",
    "註銷日期": "99\/10\/18",
    "註銷理由": "檢附資料與規定不符",
    "製造許可登錄編號": "",
    "有效日期": "97\/02\/07",
    "發證日期": "87\/02\/07",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202206606",
    "中文品名": "爾促開利注射劑１０公絲／公撮〝岱比博〞",
    "英文品名": "ATRACURIUM BESYLATE INJECTION 10MG\/ML &quot;DBL&quot;",
    "適應症": "本藥乃一高選擇性及競爭性的非去極化神經肌肉阻斷劑，可作為手術全身麻醉或加護病房鎮靜時的輔助劑，以鬆弛骨骼、幫助氣管插管及與人工呼吸器的協調。",
    "劑型": "270注射劑",
    "包裝": "安瓿 盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "ATRACURIUM BESYLATE",
    "限制項目": "02輸　入",
    "申請商名稱": "620102S342  新加坡商赫士睿股份有限公司台灣分公司",
    "申請商地址": "台北市大安區敦化南路2段333號18樓",
    "主製造廠": [
        {
            "製造廠名稱": "FAU0031100  HOSPIRA AUSTRALIA PTY LTD.",
            "製造廠廠址": "1 LEXIA PLACE, MULGRAVE, VICTORIA 3170, AUSTRALIA",
            "製造廠公司地址": "",
            "製造廠國別": "AUSTRALIA",
            "製程": ""
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1220002200",
            "成分名稱": "ATRACURIUM BESYLATE",
            "含量描述": "",
            "含量": "10.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "020220660001.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022066&Seq=001&Type=9"
        }
    ]
}